1. Home
  2. GGT vs RCEL Comparison

GGT vs RCEL Comparison

Compare GGT & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Multi-Media Trust Inc. (The)

GGT

Gabelli Multi-Media Trust Inc. (The)

N/A

Current Price

$4.20

Market Cap

145.5M

Sector

Finance

ML Signal

N/A

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

N/A

Current Price

$4.72

Market Cap

132.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GGT
RCEL
Founded
1994
N/A
Country
United States
United States
Employees
N/A
226
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.5M
132.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GGT
RCEL
Price
$4.20
$4.72
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.88
AVG Volume (30 Days)
295.4K
211.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
15.56%
N/A
EPS Growth
N/A
N/A
EPS
0.83
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$21.69
Revenue Next Year
N/A
$49.58
P/E Ratio
$5.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.75
$3.22
52 Week High
$4.94
$10.28

Technical Indicators

Market Signals
Indicator
GGT
RCEL
Relative Strength Index (RSI) 51.55 51.25
Support Level $4.13 $4.11
Resistance Level $4.29 $5.89
Average True Range (ATR) 0.07 0.37
MACD 0.01 -0.05
Stochastic Oscillator 67.69 4.62

Price Performance

Historical Comparison
GGT
RCEL

About GGT Gabelli Multi-Media Trust Inc. (The)

Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: